T. Rowe Price Associates

T. Rowe Price Associates’s Lineage Cell Therapeutics LCTX Stock Holding History

T. Rowe Price Associates’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,398	Closed	-$33K	–	3105
2025 Q1	$33K	Sell	72,398 -35,806	-33%	-$21K	﹤0.01%	2974
2024 Q4	$55K	Hold	108,204	–	–	﹤0.01%	2928
2024 Q3	$98K	Sell	108,204 -57,190	-35%	-$53K	﹤0.01%	2824
2024 Q2	$164K	Buy	165,394 +4,080	+3%	+$4.51K	﹤0.01%	2638
2024 Q1	$239K	Buy	161,314 +70,418	+77%	+$79.8K	﹤0.01%	2537
2023 Q4	$100K	Buy	90,896 +5,560	+7%	+$6.09K	﹤0.01%	2717
2023 Q3	$101K	Hold	85,336	–	–	﹤0.01%	2669
2023 Q2	$121K	Sell	85,336 -3,764	-4%	-$5.2K	﹤0.01%	2661
2023 Q1	$134K	Hold	89,100	–	–	﹤0.01%	2625
2022 Q4	$104K	Hold	89,100	–	–	﹤0.01%	2712
2022 Q3	$101K	Buy	89,100 +16,700	+23%	+$24.5K	﹤0.01%	2723
2022 Q2	$114K	Buy	72,400 +11,309	+19%	+$14.9K	﹤0.01%	2731
2022 Q1	$94K	Buy	61,091 +2,700	+5%	+$4.19K	﹤0.01%	2857
2021 Q4	$143K	Sell	58,391 -57,300	-50%	-$134K	﹤0.01%	2819
2021 Q3	$292K	Buy	115,691 +61,960	+115%	+$159K	﹤0.01%	2589
2021 Q2	$153K	Buy	53,731 +9,931	+23%	+$25.7K	﹤0.01%	2780
2021 Q1	$103K	Buy	+43,800	New	+$105K	﹤0.01%	2778

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return